Peptide profiling of casein peptide reveals its anti-diabetic effects via DPP-IV inhibition and IRS1/PI3K/AKT signaling
Food & Function · 2026 · 17 (21) · 9785-9800
DOI: 10.1039/d6fo03739a ↗Kurz gefasst
Fachartikel in der Zeitschrift Food & Function, 2026. Verfasst von Shengnan Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science, Northeast Agricultural University, Harbin, 150030, China. lchun@neau.edu.cn. Hauptthemen laut MEDLINE: Caseins, Hypoglycemic Agents, Dipeptidyl-Peptidase IV Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a growing global health burden, increasing demand for safe food-derived strategies for glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Food Science, Northeast Agricultural University, Harbin, 150030, China. lchun@neau.edu.cn.
- Heilongjiang Green Food Science Research Institute, Harbin 150028, China.
- National Center of Technology Innovation for Dairy, Hohhot 010110, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Liang, S., Li, J., Zhao, Z., He, Y., Wang, J., Zhang, L., Li, C., Liu, L., Zhang, G., & He, J. (2026). Peptide profiling of casein peptide reveals its anti-diabetic effects via DPP-IV inhibition and IRS1/PI3K/AKT signaling. Food & Function, 17(21), 9785-9800. https://doi.org/10.1039/d6fo03739a
Vancouver
Liang S, Li J, Zhao Z, He Y, Wang J, Zhang L, et al. Peptide profiling of casein peptide reveals its anti-diabetic effects via DPP-IV inhibition and IRS1/PI3K/AKT signaling. Food & Function. 2026;17(21):9785-9800. doi:10.1039/d6fo03739a
BibTeX
@article{Liang2026,
author = {Liang, Shengnan and Li, Jiarui and Zhao, Zifu and He, Yiming and Wang, Jingwen and Zhang, Lu and Li, Chun and Liu, Libo and Zhang, Guofang and He, Jian},
title = {Peptide profiling of casein peptide reveals its anti-diabetic effects via DPP-IV inhibition and IRS1/PI3K/AKT signaling},
journal = {Food & Function},
year = {2026},
volume = {17},
number = {21},
pages = {9785--9800},
doi = {10.1039/d6fo03739a}
}
EUVIMED